| Descriptor English: | Insulin, Isophane | ||||||
| Descriptor Spanish: |
Insulina Isófana
| ||||||
| Descriptor Portuguese: | Insulina Isófana | ||||||
| Descriptor French: | Insuline isophane | ||||||
| Entry term(s): |
Hagedorn Insulin, Protamine Insulin, NPH Insulin, Protamine Zinc Isophane Insulin Isophane Insulin, Regular NPH Insulin Neutral Protamine Hagedorn Insulin Protamine Hagedorn Insulin Protamine Zinc Insulin Regular Isophane Insulin Zinc Insulin, Protamine |
||||||
| Tree number(s): |
D06.472.699.587.200.300.200 D12.644.548.586.200.300.200 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007336 | ||||||
| Scope note: | An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Entry Combination: |
antagonists & inhibitors:Insulin Antagonists
|
||||||
| Pharm Action: |
Hypoglycemic Agents |
||||||
| Registry Number: | 53027-39-7 | ||||||
| CAS Type 1 Name: | Insulin Isophane | ||||||
| Public MeSH Note: | 2009; see INSULIN, NPH 2009-2011; see INSULIN, ISOPHANE 1963-2008; for INSULIN, PROTAMINE ZINC see INSULIN, LONG-ACTING 1966-2011 |
||||||
| History Note: | 2009 (1963); for INSULIN, PROTAMINE ZINC use INSULIN, LONG-ACTING 1966-2011 |
||||||
| DeCS ID: | 7505 | ||||||
| Unique ID: | D007336 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2009/01/01 | ||||||
| Date of Entry: | 1999/01/01 | ||||||
| Revision Date: | 2015/05/26 |
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Insulin, Isophane
- Preferred
Insulin, Protamine Zinc
- Related but not broader or narrower
| Concept UI |
M0011436 |
| Scope note | An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn. |
| Preferred term | Insulin, Isophane |
| Entry term(s) |
Hagedorn Insulin, Protamine Insulin, NPH Isophane Insulin Isophane Insulin, Regular NPH Insulin Neutral Protamine Hagedorn Insulin Protamine Hagedorn Insulin Regular Isophane Insulin |
| Concept UI |
M0011440 |
| Preferred term | Insulin, Protamine Zinc |
| Entry term(s) |
Protamine Zinc Insulin Zinc Insulin, Protamine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
